Comparison of Recurrence-Free Survival Between Hemihepatectomy and Non-hemihepatectomy in Patients with Hepatocellular Carcinoma ≥5 cm: A retrospective study (Orginal article)

Background As a standard anatomical liver resection procedure, hemihepatectomy offers the advantages of anatomical resection but also carries the disadvantage of removing more liver parenchyma. This retrospective study primarily evaluates the effect of hemihepatectomy on postoperative recurrence-free survival (RFS) in patients with large hepatocellular carcinoma exceeding 5 cm in diameter. Methods Data from dual-centers on HCC patients with solitary HCC ≥5 cm who underwent hepatectomy between January 2019 and December 2022 was analyzed retrospectively. Patients were categorized into hemihepatectomy and non-hemihepatectomy group based on the surgical approach. The primary endpoint was RFS. Propensity score matching (PSM) was employed to control for potential confounding variables between the two groups. Results A total of 266 enrolled patients were categorized into hemihepatectomy (n=86) and non-hemihepatectomy group (n=180). No significant difference in RFS was observed between these two groups either before (median 17.1 vs. 18.1 months, P = 0.984) or after PSM (median 20.6 vs. 18.1 months, P = 0.914). Cox regression identified AFP ≥200 ng/mL (HR = 1.866, 95% CI: 1.390-2.505,P < 0.001) and MVI positivity (HR = 1.882, 95% CI: 1.362-2.600,P < 0.001) as independent risk factors for reduced RFS. Conclusions In HCC tumors ≥5 cm, hemihepatectomy showed no significant RFS improvement compared to non-hemihepatectomy overall. Tumor biological characteristics (AFP levels and MVI status) are the primary determinants of postoperative prognosis in HCC patients.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-18
DOI
https://doi.org/10.21203/rs.3.rs-9651292/v1
Primary Topic
Hepatocellular Carcinoma Treatment and Prognosis
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Comparison of Recurrence-Free Survival Between Hemihepatectomy and Non-hemihepatectomy in Patients with Hepatocellular Carcinoma ≥5 cm: A retrospective study (Orginal article)

Jingfei Li, D. C. Zhang, Minzi Huan, Kunyuan Jiang et al.
1 links
Research Square
Hepatocellular Carcinoma Treatment and Prognosis
preprint

Comparison of Recurrence-Free Survival Between Hemihepatectomy and Non-hemihepatectomy in Patients with Hepatocellular Carcinoma ≥5 cm: A retrospective study (Orginal article)

Jingfei Li, D. C. Zhang, Minzi Huan, Kunyuan Jiang, Jun Chang
preprint en

Abstract

Background As a standard anatomical liver resection procedure, hemihepatectomy offers the advantages of anatomical resection but also carries the disadvantage of removing more liver parenchyma. This retrospective study primarily evaluates the effect of hemihepatectomy on postoperative recurrence-free survival (RFS) in patients with large hepatocellular carcinoma exceeding 5 cm in diameter. Methods Data from dual-centers on HCC patients with solitary HCC ≥5 cm who underwent hepatectomy between January 2019 and December 2022 was analyzed retrospectively. Patients were categorized into hemihepatectomy and non-hemihepatectomy group based on the surgical approach. The primary endpoint was RFS. Propensity score matching (PSM) was employed to control for potential confounding variables between the two groups. Results A total of 266 enrolled patients were categorized into hemihepatectomy (n=86) and non-hemihepatectomy group (n=180). No significant difference in RFS was observed between these two groups either before (median 17.1 vs. 18.1 months, P = 0.984) or after PSM (median 20.6 vs. 18.1 months, P = 0.914). Cox regression identified AFP ≥200 ng/mL (HR = 1.866, 95% CI: 1.390-2.505,P < 0.001) and MVI positivity (HR = 1.882, 95% CI: 1.362-2.600,P < 0.001) as independent risk factors for reduced RFS. Conclusions In HCC tumors ≥5 cm, hemihepatectomy showed no significant RFS improvement compared to non-hemihepatectomy overall. Tumor biological characteristics (AFP levels and MVI status) are the primary determinants of postoperative prognosis in HCC patients.

Research Square
University of Science and Technology of China (CN)
Good health and well-being
Hepatocellular Carcinoma Treatment and Prognosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon